JPMorgan Chase & Co’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64 | Sell |
|
|||||
|
2025
Q1 | $379 | Buy |
|
|||||
|
2024
Q4 | $300 | Sell |
|
|||||
|
2024
Q3 | $668K | Buy |
|
|||||
|
2024
Q2 | $281K | Buy |
|
|||||
|
2024
Q1 | $232K | Buy |
|
|||||
|
2023
Q4 | $53.3K | Sell |
|
|||||
|
2023
Q3 | $112K | Sell |
|
|||||
|
2023
Q2 | $356K | Sell |
|
|||||
|
2023
Q1 | $3.14M | Sell |
|
|||||
|
2022
Q4 | $2.88M | Buy |
|
|||||
|
2022
Q3 | $1.85M | Sell |
|
|||||
|
2022
Q2 | $1.51M | Buy |
|
|||||
|
2022
Q1 | $1.47M | Sell |
|
|||||
|
2021
Q4 | $1.75M | Sell |
|
|||||
|
2021
Q3 | $13M | Sell |
|
|||||
|
2021
Q2 | $59.9M | Buy |
|
|||||
|
2021
Q1 | $75.6M | Buy |
|
|||||
|
2020
Q4 | $76.7M | Buy |
|
|||||
|
2020
Q3 | $80.3M | Buy |
|
|||||
|
2020
Q2 | $72M | Buy |
|
|||||
|
2020
Q1 | $58.4M | Sell |
|
|||||
|
2019
Q4 | $78.3M | Buy |
|
|||||
|
2019
Q3 | $66.4M | Buy |
|
|||||
|
2019
Q2 | $75.1M | Buy |
|
|||||
|
2019
Q1 | $67M | Buy |
|
|||||
|
2018
Q4 | $55.4M | Buy |
|
|||||
|
2018
Q3 | $70.4M | Buy |
|
|||||
|
2018
Q2 | $66.4M | Buy |
|
|||||
|
2018
Q1 | $44.6M | Sell |
|
|||||
|
2017
Q4 | $49.5M | Buy |
|
|||||
|
2017
Q3 | $54.1M | Sell |
|
|||||
|
2017
Q2 | $34.6M | Sell |
|
|||||
|
2017
Q1 | $28M | Buy |
|
|||||
|
2016
Q4 | $22.7M | Sell |
|
|||||
|
2016
Q3 | $22.3M | Sell |
|
|||||
|
2016
Q2 | $21.1M | Buy |
|
|||||
|
2016
Q1 | $27.2M | Sell |
|
|||||
|
2015
Q4 | $53.4M | Buy |
|
|||||
|
2015
Q3 | $35.2M | Buy |
|
|||||
|
2015
Q2 | $37.7M | Buy |
|
|||||
|
2015
Q1 | $15.1M | Sell |
|
|||||
|
2014
Q4 | $20.9M | Buy |
|